Microbial Metabolites

Overview

Microbial metabolites are the chemical products of microbial metabolism that act as signaling molecules, nutrients, or toxins within and beyond the gut. They are the functional output of the microbiome — the mechanism by which microbial composition translates into host physiology and disease. With 418 source mentions across the vault, metabolites are the most frequently discussed functional concept in WikiBiome.

Major Metabolite Classes

Short-Chain Fatty Acids (SCFAs)

The most studied beneficial microbial metabolites. See short chain fatty acids, butyrate, propionic acid.

  • Butyrate: Colonocyte fuel, HDAC inhibitor, barrier protector, anti-inflammatory via GPR109A.
  • Propionate: Hepatic gluconeogenesis modulator; anti-inflammatory.
  • Acetate: Most abundant SCFA; appetite regulation, peripheral metabolism.

Trimethylamine N-Oxide (TMAO)

Microbial metabolism of choline/carnitine → TMA → hepatic oxidation → TMAO. Pro-atherosclerotic. See dedicated page.

Bile Acid Metabolites

Bacterial bile salt hydrolases (BSH) deconjugate primary bile acids; 7α-dehydroxylases convert to secondary bile acids. See bile acid metabolism.

Tryptophan Metabolites

Microbial tryptophan metabolism produces indoles (indoles), kynurenine pathway intermediates, and serotonin precursors. These activate AhR (aryl hydrocarbon receptor) and modulate gut brain axis signaling.

Neuroactive Metabolites

  • GABA: Produced by Lactobacillus, Bifidobacterium via glutamate decarboxylase.
  • serotonin: ~95% of body serotonin produced in the gut, modulated by microbial metabolites.
  • Dopamine precursors: Microbial tyrosine decarboxylase.

Uremic Toxins

  • p-Cresol sulfate, indoxyl sulfate: Microbial metabolites that accumulate in CKD, driving cardiovascular and neurological complications.

Gaseous Metabolites

  • hydrogen sulfide: Produced by sulfate-reducing bacteria; cytotoxic at high concentrations, signaling molecule at low concentrations.
  • H₂: Substrate for nickel-dependent NiFe-hydrogenases in pathogenic Enterobacteriaceae.

Metal-Metabolite Interface

Microbial metabolites and metals interact bidirectionally:

  • SCFA production requires iron-sulfur cluster enzymes (butyryl-CoA dehydrogenase) — metal availability directly affects metabolite output.
  • Siderophores are themselves metabolites — iron-chelating molecules that shape both microbial ecology and host iron homeostasis.
  • Metal exposure alters metabolite profiles: Cadmium exposure shifts fecal metabolomics, reducing beneficial SCFAs and increasing uremic toxin precursors.

Cross-References

References (7)

  1. Neil Daniel, Riccardo Farinella, Anastasia Chrysovalantou Chatziioannou et al. (2024). Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study. Scientific Reports. doi:10.1038/s41598-024-77431-5
  2. Denise Mafra, Natalia A. Borges, Livia Alvarenga et al. (2022). Fermented Food: Should Patients with Cardiometabolic Diseases Go Back to an Early Neolithic Diet?. Critical Reviews in Food Science and Nutrition. doi:10.1080/10408398.2022.2077300
  3. Qiang Luo, Yilan Hu, Xin Chen et al. (2022). Effects of Gut Microbiota and Metabolites on Heart Failure and Its Risk Factors: A Two-Sample Mendelian Randomization Study. Frontiers in Nutrition. doi:10.3389/fnut.2022.899746
  4. Zhexin Ni, Shuai Sun, Yanli Bi et al. (2020). Ni 2020 — Fecal Metabolomics and Gut Microbiota Correlation in Endometriosis Mice. American Journal of Reproductive Immunology. doi:10.1111/aji.13307
  5. Tomohiro Hayashi, Tomoya Yamashita, Hikaru Watanabe et al. (2019). Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure. Circulation Journal. doi:10.1253/circj.CJ-18-0468
  6. Liu H, Liu H, Liu C et al. (2022). Liu et al. 2022 — Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease. Frontiers in Molecular Biosciences. doi:10.3389/fmolb.2022.841223
  7. Tiffany L Weir, Daniel K Manter, Amy M Sheflin et al. (2013). Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults. PLoS ONE. doi:10.1371/journal.pone.0070803

Related Articles